Kunkel Lori Anne
Director
Exercise
Calculated transaction value
$133.59K
7,300 shares @ $18.3
Traded
Oct 30, 2026
Filed
Nov 3, 2026
You're reading the free version. Trader adds the live tape and alerts.
Start tracking
Enliven Therapeutics
ELVN
ManufacturingChemicals
Transactions reported in official disclosures
Price with disclosed trades
Daily closes, past year · marks sit on transaction dates, sized by value
74 trades
| Reporting person | Filed | Transaction | Transaction value | Source | Actions |
|---|---|---|---|---|---|
| Kunkel Lori Anne Director | Nov 3, 2026 4-day lag | Exercise Oct 30, 2026 | $133.59K Filed shares x price | SEC Form 4 View filing | |
| Kunkel Lori Anne Director | Nov 3, 2026 4-day lag | Exercise Oct 30, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Kunkel Lori Anne Director | Nov 3, 2026 4-day lag | Exercise Oct 30, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Kunkel Lori Anne Director | Nov 3, 2026 4-day lag | Exercise Oct 30, 2026 | $4.19K Filed shares x price | SEC Form 4 View filing | |
| Hohl Benjamin Chief Financial Officer | Oct 21, 2026 2-day lag | Exercise Oct 19, 2026 | $89.37K Filed shares x price | SEC Form 4 View filing | |
| Hohl Benjamin Chief Financial Officer | Oct 21, 2026 2-day lag | Sale Oct 19, 2026 | $231.55K Filed shares x price | SEC Form 4 View filing | |
| Hohl Benjamin Chief Financial Officer | Oct 21, 2026 2-day lag | Exercise Oct 19, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Collins Helen Louise Chief Medical Officer | Oct 21, 2026 2-day lag | Exercise Oct 19, 2026 | $12.4K Filed shares x price | SEC Form 4 View filing | |
| Collins Helen Louise Chief Medical Officer | Oct 21, 2026 2-day lag | Exercise Oct 19, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Collins Helen Louise Chief Medical Officer | Oct 21, 2026 2-day lag | Sale Oct 19, 2026 | $192.34K Filed shares x price | SEC Form 4 View filing | |
| Ball Kristine M Director | Oct 16, 2026 2-day lag | Award Oct 14, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Garland J. Scott Director | Oct 5, 2026 4-day lag | Sale Oct 1, 2026 | $606.72K Filed shares x price | SEC Form 4 View filing | |
| Garland J. Scott Director | Oct 5, 2026 4-day lag | Exercise Oct 1, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Garland J. Scott Director | Oct 5, 2026 4-day lag | Exercise Oct 1, 2026 | $201.11K Filed shares x price | SEC Form 4 View filing | |
| Hohl Benjamin Chief Financial Officer | Sep 21, 2026 4-day lag | Sale Sep 17, 2026 | $14.88K Filed shares x price | SEC Form 4 View filing | |
| Hohl Benjamin Chief Financial Officer | Sep 21, 2026 4-day lag | Exercise Sep 17, 2026 | $59.13K Filed shares x price | SEC Form 4 View filing | |
| Hohl Benjamin Chief Financial Officer | Sep 21, 2026 4-day lag | Sale Sep 17, 2026 | $111.27K Filed shares x price | SEC Form 4 View filing | |
| Hohl Benjamin Chief Financial Officer | Sep 21, 2026 4-day lag | Exercise Sep 17, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Hohl Benjamin Chief Financial Officer | Sep 21, 2026 4-day lag | Sale Sep 17, 2026 | $176.85K Filed shares x price | SEC Form 4 View filing | |
| Collins Helen Louise Chief Medical Officer | Sep 21, 2026 4-day lag | Sale Sep 17, 2026 | $12.36K Filed shares x price | SEC Form 4 View filing | |
| Collins Helen Louise Chief Medical Officer | Sep 21, 2026 4-day lag | Sale Sep 17, 2026 | $93.51K Filed shares x price | SEC Form 4 View filing | |
| Collins Helen Louise Chief Medical Officer | Sep 21, 2026 4-day lag | Exercise Sep 17, 2026 | $12.4K Filed shares x price | SEC Form 4 View filing | |
| Collins Helen Louise Chief Medical Officer | Sep 21, 2026 4-day lag | Sale Sep 17, 2026 | $145.89K Filed shares x price | SEC Form 4 View filing | |
| Collins Helen Louise Chief Medical Officer | Sep 21, 2026 4-day lag | Exercise Sep 17, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Hohl Benjamin Chief Financial Officer | Aug 19, 2026 2-day lag | Sale Aug 17, 2026 | $82.38K Filed shares x price | SEC Form 4 View filing | |
| Hohl Benjamin Chief Financial Officer | Aug 19, 2026 2-day lag | Sale Aug 17, 2026 | $270.17K Filed shares x price | SEC Form 4 View filing | |
| Collins Helen Louise Chief Medical Officer | Aug 19, 2026 2-day lag | Exercise Aug 17, 2026 | $12.4K Filed shares x price | SEC Form 4 View filing | |
| Collins Helen Louise Chief Medical Officer | Aug 19, 2026 2-day lag | Exercise Aug 17, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Collins Helen Louise Chief Medical Officer | Aug 19, 2026 2-day lag | Sale Aug 17, 2026 | $65.28K Filed shares x price | SEC Form 4 View filing | |
| Collins Helen Louise Chief Medical Officer | Aug 19, 2026 2-day lag | Sale Aug 17, 2026 | $227.65K Filed shares x price | SEC Form 4 View filing |
Kunkel Lori Anne
Director
Exercise
Calculated transaction value
$0
7,300 shares @ $0
Traded
Oct 30, 2026
Filed
Nov 3, 2026
Kunkel Lori Anne
Director
Exercise
Calculated transaction value
$0
3,741 shares @ $0
Traded
Oct 30, 2026
Filed
Nov 3, 2026
Kunkel Lori Anne
Director
Exercise
Calculated transaction value
$4.19K
3,741 shares @ $1.12
Traded
Oct 30, 2026
Filed
Nov 3, 2026
Hohl Benjamin
Chief Financial Officer
Exercise
Calculated transaction value
$89.37K
6,018 shares @ $14.85
Traded
Oct 19, 2026
Filed
Oct 21, 2026
Hohl Benjamin
Chief Financial Officer
Sale
Calculated transaction value
$231.55K
6,018 shares @ $38.48
Traded
Oct 19, 2026
Filed
Oct 21, 2026
Hohl Benjamin
Chief Financial Officer
Exercise
Calculated transaction value
$0
6,018 shares @ $0
Traded
Oct 19, 2026
Filed
Oct 21, 2026
Collins Helen Louise
Chief Medical Officer
Exercise
Calculated transaction value
$12.4K
5,000 shares @ $2.48
Traded
Oct 19, 2026
Filed
Oct 21, 2026
Collins Helen Louise
Chief Medical Officer
Exercise
Calculated transaction value
$0
5,000 shares @ $0
Traded
Oct 19, 2026
Filed
Oct 21, 2026
Collins Helen Louise
Chief Medical Officer
Sale
Calculated transaction value
$192.34K
5,000 shares @ $38.47
Traded
Oct 19, 2026
Filed
Oct 21, 2026
Ball Kristine M
Director
Award
Calculated transaction value
$0
23,394 shares @ $0
Traded
Oct 14, 2026
Filed
Oct 16, 2026
Garland J. Scott
Director
Sale
Calculated transaction value
$606.72K
13,000 shares @ $46.67
Traded
Oct 1, 2026
Filed
Oct 5, 2026
Garland J. Scott
Director
Exercise
Calculated transaction value
$0
13,000 shares @ $0
Traded
Oct 1, 2026
Filed
Oct 5, 2026
Garland J. Scott
Director
Exercise
Calculated transaction value
$201.11K
13,000 shares @ $15.47
Traded
Oct 1, 2026
Filed
Oct 5, 2026
Hohl Benjamin
Chief Financial Officer
Sale
Calculated transaction value
$14.88K
289 shares @ $51.49
Traded
Sep 17, 2026
Filed
Sep 21, 2026
Hohl Benjamin
Chief Financial Officer
Exercise
Calculated transaction value
$59.13K
3,982 shares @ $14.85
Traded
Sep 17, 2026
Filed
Sep 21, 2026
Hohl Benjamin
Chief Financial Officer
Sale
Calculated transaction value
$111.27K
2,194 shares @ $50.72
Traded
Sep 17, 2026
Filed
Sep 21, 2026
Hohl Benjamin
Chief Financial Officer
Exercise
Calculated transaction value
$0
3,982 shares @ $0
Traded
Sep 17, 2026
Filed
Sep 21, 2026
Hohl Benjamin
Chief Financial Officer
Sale
Calculated transaction value
$176.85K
3,535 shares @ $50.03
Traded
Sep 17, 2026
Filed
Sep 21, 2026
Collins Helen Louise
Chief Medical Officer
Sale
Calculated transaction value
$12.36K
240 shares @ $51.48
Traded
Sep 17, 2026
Filed
Sep 21, 2026
Collins Helen Louise
Chief Medical Officer
Sale
Calculated transaction value
$93.51K
1,844 shares @ $50.71
Traded
Sep 17, 2026
Filed
Sep 21, 2026
Collins Helen Louise
Chief Medical Officer
Exercise
Calculated transaction value
$12.4K
5,000 shares @ $2.48
Traded
Sep 17, 2026
Filed
Sep 21, 2026
Collins Helen Louise
Chief Medical Officer
Sale
Calculated transaction value
$145.89K
2,916 shares @ $50.03
Traded
Sep 17, 2026
Filed
Sep 21, 2026
Collins Helen Louise
Chief Medical Officer
Exercise
Calculated transaction value
$0
5,000 shares @ $0
Traded
Sep 17, 2026
Filed
Sep 21, 2026
Hohl Benjamin
Chief Financial Officer
Sale
Calculated transaction value
$82.38K
1,388 shares @ $59.35
Traded
Aug 17, 2026
Filed
Aug 19, 2026
Hohl Benjamin
Chief Financial Officer
Sale
Calculated transaction value
$270.17K
4,630 shares @ $58.35
Traded
Aug 17, 2026
Filed
Aug 19, 2026
Collins Helen Louise
Chief Medical Officer
Exercise
Calculated transaction value
$12.4K
5,000 shares @ $2.48
Traded
Aug 17, 2026
Filed
Aug 19, 2026
Collins Helen Louise
Chief Medical Officer
Exercise
Calculated transaction value
$0
5,000 shares @ $0
Traded
Aug 17, 2026
Filed
Aug 19, 2026
Collins Helen Louise
Chief Medical Officer
Sale
Calculated transaction value
$65.28K
1,100 shares @ $59.35
Traded
Aug 17, 2026
Filed
Aug 19, 2026
Collins Helen Louise
Chief Medical Officer
Sale
Calculated transaction value
$227.65K
3,900 shares @ $58.37
Traded
Aug 17, 2026
Filed
Aug 19, 2026